Navigation Links
'Topical Dermatological Product Development in the USA' Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USA
Date:4/9/2009

Featuring US experts in topical dermatological drug development

PETALUMA, Calif., April 9 /PRNewswire/ -- Dow Pharmaceutical Sciences, Inc. today announced that it will hold a 1-day workshop on "Topical Dermatological Product Development in the USA" June 4, 2009 at the Hilton East Brunswick, New Jersey.

This workshop will focus on the unique problems and issues confronted during development of topical dermatological drugs intended for the US market.

"Our line-up of dermatological experts for this workshop is exceptional," said Gordon Dow, Founder and Chief Technical Officer at Dow Pharmaceutical Sciences. "Anyone considering development of a topical dermatological product should benefit from attending this focused workshop."

The morning session will cover formulation and screening of topical products for regulatory, clinical and commercial success, CMC issues and pitfalls, and the role of project management in successful development programs.

The afternoon session will cover FDA safety concerns and non-clinical requirements, clinical endpoints and trial designs. The FDA perspective will be presented by the retired founding director of the FDA Dermatology Division, including strategies for successful FDA meetings.

A Q&A roundtable to include all speakers will conclude the program.

A reception from 5-7PM on June 3rd will be hosted by Dow Pharmaceutical Sciences, Inc.

See www.dowpharmsci.com for information on this exciting workshop.

    Contact:
    Vanlee Waters, Dow Pharmaceutical Sciences at 707.796.7239
    E-mail: vwaters@dowpharmsci.com


'/>"/>
SOURCE Dow Pharmaceutical Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
2. Topical Spray Helped Men With Premature Ejaculation
3. Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
4. Global Warming Expected to Spike Pollen and Spring Allergies - New Drug-Free Topical Gels Boost Hope for Allergy Sufferers
5. Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis
6. The Texas Institute of Dermatology Team Finds Easy-to-Apply, Topical Drug Just as Good as Injectable Compound for a Disfigurating Skin Infection
7. NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009
8. American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies
9. High and Super-High Potency Topical Corticosteroids Will Remain Decision Resources Clinical Gold Standard Through 2017 for the Treatment of Atopic Dermatitis
10. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
11. Ready-To-Use Products Spur the European Tissue Sealants and Topical Hemostats Markets, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Ohio (PRWEB) , ... August 04, 2015 , ... ... have up-to-date immunizations, especially those entering kindergarten. All required immunizations are covered for ... rules, which means that children who aren’t caught up with their immunizations may ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... label design, product packaging, and fulfillment services, joined over 200 other Long Island-based ... was held on Tuesday, July 28th at Jones Beach State Park in Wantagh, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... patients whose cancer has come back: Retreatment may be a viable option. Surviving ... read it now. , According to surgeons at the University of New ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... and other long-term care facilities, today announced details of the Advanced level of ... and centers. , Providigm’s QAPI Accreditation program , introduced in 2013, is ...
(Date:8/4/2015)... ... 04, 2015 , ... A new report by The 2112 ... will grow at least 6 percent in 2015, as solution providers expand sales, ... their OEM/vendor partners. , The 2112 Group’s 2015 Midyear Channel Performance Report ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 2Health News:The 2112 Group Forecasts North America IT Channel to Grow At Least 6% in 2015 3
... developing clothing, which they say will be able to monitor ... sensors designed to monitor body fluids such as blood and ... use the clothes to check on groups such as recovering ... ,As of now, the Biotex programme, which is ...
... of psychologists from Durham University and two Polish institutions ... their fathers are more likely to select partners ... negative or less positive relationships were not attracted to ... ,Due to be published in the July issue of ...
... total economic shutdown as some 2 million public servants ... 'It's going to be a total shutdown tomorrow in public ... involving marches in major cities and pickets outside government buildings,' ... Trade Unions (COSATU) labor federation had warned Tuesday. ...
... (CNBG) led by Madam Wang Lifeng, President and CEO ... Union Minister for Health & Family Welfare , Dr. ... CNBG is Government owned, the largest vaccine manufacturer and ... discussed the supply live of JE vaccine in order ...
... than leave you short-tempered: it can also stress your ... death, according to a study released Wednesday . ... sleep loss have been well-documented, ranging from lowered concentration ... by researchers at the University of Pennsylvania School of ...
... both houses of the Legislature are on the brink of ... the Assembly's bill is Manhattan Assemblyman Richard Gottfried , who ... serious medical conditions who could have a better quality and ... a person would have to have a debilitating or life-threatening ...
Cached Medicine News:Health News:Scientists Developing 'intelligent Clothes' to Monitor Wearer's Health 2Health News:Women Choose Their Men With Their Fathers Resemblance 2Health News:South Africa Facing Major Economic Shutdown as Health Workers are Sacked En Masse 2Health News:Chinese Delegation Meets Health Minister Regarding Japanese Encephalitis Vaccine Supply 2Health News:Insufficient Sleep Increases Risk of Cardiovascular Disease: Study 2Health News:Medical Marijuana to Be Legalized 2
(Date:8/3/2015)... CITY, Calif., Aug. 3, 2015 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies ... business update and reported financial results for the three ... Business highlights include: , On July 23, 2015, ... adopted a positive opinion for Zalviso™ for the management ...
(Date:8/3/2015)... -- Your doctor has recommended surgery for your foot ... possible outcome. Your orthopaedic foot and ankle specialist is ... a three-part online series to help you ... Orthopaedic Foot & Ankle Society (AOFAS) both before ... heal as quickly as possible. For example, ...
(Date:8/3/2015)... N.Y. , Aug. 3, 2015 Par ... a conference call on Friday, August 7, 2015 at ... for the second quarter ended June 30, 2015.  Par ... available to the public in its filings with the ... information available on its website by following the instructions ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10Patient Guide: How to Prepare for Surgery 2
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today ... 2010.  Third quarter 2010 net revenues were $42.0 million, ... 2009.  Excluding the recognition of one-time license revenue in ... 44%.  Net loss for the third quarter ended September ...
... 2, 2010 Cannabis Science, Inc. (OTC Bulletin Board: ... cannabis products, is pleased to announce to its shareholders and ... decisions and processes regarding the new class of common shares. ... 1 for 10 new share dividend payment for shareholders of ...
Cached Medicine Technology:ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 2ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 3ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 4ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 5ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 6ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 7ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 8ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 9ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results 10Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010 2Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010 3
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
Finesse electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
The Aaron 800-EU is designed and engineered to be the most reliable and durable desiccator available today....
Medicine Products: